The biggest myths about prostate cancer after Giles Coren diagnosis - Prostate cancer is often seen as an unavoidable part of ...

Prostate cancer is the second most common cancer affecting men globally, with diagnostic methods and risk assessment remaining a challenge despite decades of research. For years, the prostate-specific ...

Some oncologists suggest that, for certain early cancers not at risk of spreading, the term “cancer” should be avoided.

Prostate cancer is often seen as an unavoidable part of ageing, especially among men, but there are many myths that can ...

In a video interview, William K. Oh, MD, director of precision medicine at Yale Cancer Center and Smilow Cancer Hospital discusses the latest breakthroughs in advanced prostate cancer treatment.

David James, director of patient projects and influencing at Prostate Cancer Research, has set the record straight on some of ...

On Friday, food critic Giles Coren revealed he had this week been diagnosed with the disease. According to Coren, 55, doctors ...

Oncotype DX Genomic Prostate Score (GPS), and Prolaris—can aid doctors in treating early-stage prostate cancer. Published in the Annals of Internal Medicine, the review highlights that these ...

The new urine test looks at 18 genes that are linked to high-risk prostate cancer. Previous research showed that MPS2 could ...

Prostate cancer is the most common cancer diagnosed in men, and the second most common cancer in the world, and while the outlook can be hopeful if caught early, treatment can impact a patient’s ...

A new test for prostate cancer developed by Irish and Swedish researchers better predicts the risks of the aggressive disease ...